Desonide Ointment, 0.05% NDC 72162-1272

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-1272Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-1272Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-1272-2	72162127202	1 TUBE in 1 CARTON (72162-1272-2) / 15 g in 1 TUBEMarketed from Mar 20, 2019
72162-1272-6	72162127206	1 TUBE in 1 CARTON (72162-1272-6) / 60 g in 1 TUBEMarketed from Mar 20, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desonide Ointment, 0.05%
Generic name (nonproprietary): desonide ointment, 0.05%
Active ingredients: Desonide — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210998
Marketing start: Mar 20, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 72162-1272_e66009c7-8812-4765-8a81-8d215b72dd47SPL ID e66009c7-8812-4765-8a81-8d215b72dd47SPL set ID d5fb23d8-a39e-4cf9-9a89-2de9dfafbb4dRxCUI 204135UNII J280872D1O
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162127202 followed by a unit qualifier and the quantity

Package 72162-1272-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Desonide Ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210998

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210998
Product	Strength	Form · route	Labeler	Product NDC
Desonide Ointment, 0.05%	Desonide .5 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8481
Desonide Ointment, 0.05%	Desonide .5 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8482
Desonide Ointment, 0.05%	Desonide .5 mg/g	OintmentTopical	Encube Ethicals, Inc.	21922-004